(b) Challenges and future work of the Commission on Narcotic Drugs, the World Health Organization and the International Narcotics Control Board in the review of substances for possible scheduling recommendations (c) International Narcotics Control Board (d) International cooperation to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes while preventing …
World Health Organization (WHO)
Informal dialogue with the WHO
Lucía Goberna (VNGOC): Welcome Vladimir Pozniak (WHO): Thank you for being here, we hope this will become a tradition at CND. Kenzi Riboulet (FAAAT): There are three departments of WHO concerned with matters related to controlled drugs: Health products (EMP), Substance abuse (MSA), and Traditional/Complementary medicine (T&CM). What collaboration, coordination or cooperation exists between these …
Item 3: General debate (continued)
Chair of the CND: We will continue with Item 3. Nepal: Nepal aligns itself with the statement of G-77 and Asia-Pacific Group. Illicit cultivation, production, manufacture, trafficking and consumption are putting profound impacts on security and development of the world. Yet, it is heartening to note that the world community has formally recognised the aim …
Side event: Drug reform: From a punitive to a supportive approach – The Norwegian proposal
Minister Bent Høie, Norway: Our attitudes and understandings of drugs have changed over the last years. The policy area has evolved but within the same framework: prohibition and sanctions are effective and reasonable. I have to admit, I have been in favour of this paradigm. Gradually, this approach has been questioned and criticised by more …
CND 62nd Session Reconvened – Friday, 13 December 2019
Chair: Welcome. Yuri Fedotov, UNODC: Today I am addressing you for the last time. As regular budgetary sources decreased, we were able to rely on your voluntary contribution, which I am sure will continue to allow us to deliver as you expected. We have come to a place of pressure as the whole UN system …
Thematic sessions – Follow up to the 2019 Ministerial Declaration, 18 October
Third round of thematic sessions on the implementation of all international drug policy commitments following up to the 2019 Ministerial Declaration Theme addressed: ‘… synthetic opioids and the non-medical use of prescription drugs pose increasing risks to public health and safety, as well as scientific, legal and regulatory challenges, including with regard to the scheduling of substances’ Background …